# Effect of Intraarticular Injection of Tenoxicam and Hyaluronic Acid Versus Platelet-Rich Plasma and Hyaluronic Acid in Temporomandibular Joint Internal Derangement

> **NCT06572904** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Mansoura University** · enrollment: 60 (actual)

## Conditions studied

- Temporomandibular Joint Internal Derangement

## Interventions

- **DRUG:** Tenoxicam Injectable Product
- **DRUG:** Hyaluronic Acid 20 MG/1 ML Injection Gel/Jelly

## Key facts

- **NCT ID:** NCT06572904
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-20
- **Primary completion:** 2024-10-20
- **Final completion:** 2024-11-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06572904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06572904, "Effect of Intraarticular Injection of Tenoxicam and Hyaluronic Acid Versus Platelet-Rich Plasma and Hyaluronic Acid in Temporomandibular Joint Internal Derangement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06572904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*